Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by PARKHILL KAREN L, Chief Financial Officer. Officer active across 3 companies, notably Medtronic plc. Cumulatively, 13 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €130k. Activity tracked since 15 June 2021. The latest transaction was filed on 5 August 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Karen L. Parkhill serves as Executive Vice President and Chief Financial Officer at Medtronic plc. She oversees the company's financial operations, ensuring compliance and transparency in financial reporting. Her financial expertise is essential for Medtronic's strategy and growth.